{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T16:30:36Z","timestamp":1786379436200,"version":"build-2736575974"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Tianjin Health Science and Technology Project","award":["TJWJ2022QN071"],"award-info":[{"award-number":["TJWJ2022QN071"]}]},{"name":"Tianjin Key Medical Discipline(Specialty) Construction Project","award":["TJYXZDXK-3-017B"],"award-info":[{"award-number":["TJYXZDXK-3-017B"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Cardiovasc. Transl. Res."],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s12265-026-10827-y","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:31:42Z","timestamp":1786372302000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nicotinamide Mononucleotide Ameliorates Myocardial Fibrosis in Diabetic Mice Possibly by Modulating SIRT3 to Deacetylate GSK3\u03b2 and Thereby Reducing the Phosphorylation of Smad3"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-7107-5204","authenticated-orcid":false,"given":"Zuowang","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"issue":"7","key":"10827_CR1","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41569-020-00504-1","volume":"18","author":"B L\u00f3pez","year":"2021","unstructured":"L\u00f3pez B, Ravassa S, Moreno MU, et al. Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches[J]. Nat Rev Cardiol. 2021;18(7):479\u201398.","journal-title":"Nat Rev Cardiol"},{"key":"10827_CR2","doi-asserted-by":"crossref","unstructured":"Levick SP, Widiapradja A. The diabetic cardiac fibroblast: mechanisms underlying phenotype and function[J]. Int J Mol Sci. 2020;21(3).","DOI":"10.3390\/ijms21030970"},{"issue":"1","key":"10827_CR3","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12933-019-0964-4","volume":"18","author":"Q Shao","year":"2019","unstructured":"Shao Q, Meng L, Lee S, et al. Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet\/streptozotocin-induced diabetic rats[J]. Cardiovasc Diabetol. 2019;18(1):165.","journal-title":"Cardiovasc Diabetol"},{"issue":"22","key":"10827_CR4","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1111\/bph.15820","volume":"180","author":"A Sharma","year":"2023","unstructured":"Sharma A, De Blasio M, Ritchie R. Current challenges in the treatment of cardiac fibrosis: Recent insights into the sex-specific differences of glucose-lowering therapies on the diabetic heart: IUPHAR Review 33[J]. Br J Pharmacol. 2023;180(22):2916\u201333.","journal-title":"Br J Pharmacol"},{"key":"10827_CR5","doi-asserted-by":"crossref","unstructured":"Espeland T, Lunde IG, B H A et al. Myocardial fibrosis[J]. Tidsskr Nor Laegeforen, 2018;138(16).","DOI":"10.4045\/tidsskr.17.1027"},{"issue":"15","key":"10827_CR6","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1016\/j.jacc.2018.02.021","volume":"71","author":"A Gonz\u00e1lez","year":"2018","unstructured":"Gonz\u00e1lez A, Schelbert EB, D\u00edez J, et al. Myocardial Interstitial Fibrosis in Heart Failure: Biological and Translational Perspectives[J]. J Am Coll Cardiol. 2018;71(15):1696\u2013706.","journal-title":"J Am Coll Cardiol"},{"key":"10827_CR7","doi-asserted-by":"crossref","unstructured":"Jiang Y, Xu Z, Sun X et al. Photobiomodulation therapy inhibits ISO-induced myocardial remodeling in mice through modulating TGF-\u03b2\/Smad7 and PI3K\/AKT pathways[J]. Photodiagnosis Photodyn Ther. 2026;105389.","DOI":"10.1016\/j.pdpdt.2026.105389"},{"key":"10827_CR8","doi-asserted-by":"publisher","first-page":"116413","DOI":"10.1016\/j.biopha.2024.116413","volume":"173","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Yang Z, Wang S, et al. Targeting MAPK-ERK\/JNK pathway: A potential intervention mechanism of myocardial fibrosis in heart failure[J]. Biomed Pharmacother. 2024;173:116413.","journal-title":"Biomed Pharmacother"},{"key":"10827_CR9","doi-asserted-by":"publisher","first-page":"114642","DOI":"10.1016\/j.biopha.2023.114642","volume":"162","author":"S Fan","year":"2023","unstructured":"Fan S, Xiao G, Ni J, et al. Guanxinning injection ameliorates cardiac remodeling in HF mouse and 3D heart spheroid models via p38\/FOS\/MMP1-mediated inhibition of myocardial hypertrophy and fibrosis[J]. Biomed Pharmacother. 2023;162:114642.","journal-title":"Biomed Pharmacother"},{"key":"10827_CR10","doi-asserted-by":"publisher","first-page":"176900","DOI":"10.1016\/j.ejphar.2024.176900","volume":"982","author":"HJ Hu","year":"2024","unstructured":"Hu HJ, Wang XH, Zhang ZZ, et al. SIRT3 sulfhydration using hydrogen sulfide inhibited angiotensin II-induced atrial fibrosis and vulnerability to atrial fibrillation via suppression of the TGF-\u03b21\/smad2\/3 signalling pathway[J]. Eur J Pharmacol. 2024;982:176900.","journal-title":"Eur J Pharmacol"},{"issue":"16","key":"10827_CR11","doi-asserted-by":"publisher","first-page":"4624","DOI":"10.1111\/jcmm.17415","volume":"26","author":"J Mu","year":"2022","unstructured":"Mu J, Chen H, Ye M, et al. Acacetin resists UVA photoaging by mediating the SIRT3\/ROS\/MAPKs pathway[J]. J Cell Mol Med. 2022;26(16):4624\u20138.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"10827_CR12","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1111\/ejn.16371","volume":"60","author":"HJ Zuo","year":"2024","unstructured":"Zuo HJ, Ren XQ, Shi JS, et al. Gastrodin regulates the expression of renin-angiotensin system-SIRT3 and proinflammatory mediators in reactive astrocytes via activated microglia[J]. Eur J Neurosci. 2024;60(1):3677\u201393.","journal-title":"Eur J Neurosci"},{"key":"10827_CR13","doi-asserted-by":"crossref","unstructured":"Liu X, Deng R, Wei X et al. Jian-Pi-Yi-Shen formula enhances perindopril inhibition of chronic kidney disease progression by activation of SIRT3, modulation of mitochondrial dynamics, and antioxidant effects[J]. Biosci Rep. 2021;41(10).","DOI":"10.1042\/BSR20211598"},{"issue":"13","key":"10827_CR14","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.2174\/1389557516666160620095103","volume":"18","author":"X Bai","year":"2018","unstructured":"Bai X, Yao L, Ma X, et al. Small Molecules as SIRT Modulators[J]. Mini Rev Med Chem. 2018;18(13):1151\u20137.","journal-title":"Mini Rev Med Chem"},{"key":"10827_CR15","doi-asserted-by":"publisher","first-page":"108639","DOI":"10.1016\/j.pharmthera.2024.108639","volume":"257","author":"Y Ning","year":"2024","unstructured":"Ning Y, Dou X, Wang Z, et al. SIRT3: A potential therapeutic target for liver fibrosis[J]. Pharmacol Ther. 2024;257:108639.","journal-title":"Pharmacol Ther"},{"issue":"4","key":"10827_CR16","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.molcel.2019.06.008","volume":"75","author":"T Wang","year":"2019","unstructured":"Wang T, Cao Y, Zheng Q, et al. SENP1-Sirt3 Signaling Controls Mitochondrial Protein Acetylation and Metabolism[J]. Mol Cell. 2019;75(4):823\u2013e8345.","journal-title":"Mol Cell"},{"issue":"1","key":"10827_CR17","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41392-024-01816-1","volume":"9","author":"F Peng","year":"2024","unstructured":"Peng F, Liao M, Jin W, et al. 2-APQC, a small-molecule activator of Sirtuin-3 (SIRT3), alleviates myocardial hypertrophy and fibrosis by regulating mitochondrial homeostasis[J]. Signal Transduct Target Ther. 2024;9(1):133.","journal-title":"Signal Transduct Target Ther"},{"issue":"39","key":"10827_CR18","doi-asserted-by":"publisher","first-page":"e17248","DOI":"10.1002\/advs.202417248","volume":"12","author":"J Wang","year":"2025","unstructured":"Wang J, Ren X, Lu H, et al. Restoration of SIRT3 Expression in Aged Mice Alleviates UUO-Induced Renal Fibrosis by Reducing GSK-3\u03b2 Hyperacetylation[J]. Adv Sci (Weinh). 2025;12(39):e17248.","journal-title":"Adv Sci (Weinh)"},{"issue":"13","key":"10827_CR19","doi-asserted-by":"publisher","first-page":"e70761","DOI":"10.1096\/fj.202500369RR","volume":"39","author":"M Jiang","year":"2025","unstructured":"Jiang M, Lin L, Yue S, et al. Mitochondrial Calcium Uniporter-Mediated Regulation of the SIRT3\/GSK3\u03b2\/\u03b2-Catenin Signaling Pathway in Vascular Remodeling[J]. Faseb j. 2025;39(13):e70761.","journal-title":"Faseb j"},{"issue":"6","key":"10827_CR20","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s12012-022-09733-x","volume":"22","author":"SS Alavi","year":"2022","unstructured":"Alavi SS, Joukar S, Rostamzadeh F, et al. Exercise Training Attenuates Cardiac Vulnerability and Promotes Cardiac Resistance to Isoproterenol-Induced Injury Following Hookah Smoke Inhalation in Male Rats: Role of Klotho and Sirtuins[J]. Cardiovasc Toxicol. 2022;22(6):501\u201314.","journal-title":"Cardiovasc Toxicol"},{"key":"10827_CR21","doi-asserted-by":"crossref","unstructured":"Sayas CL, \u00c1vila J. GSK-3 and Tau: A key duet in alzheimer\u2019s disease[J]. Cells 2021;10(4).","DOI":"10.3390\/cells10040721"},{"issue":"6","key":"10827_CR22","doi-asserted-by":"publisher","first-page":"166724","DOI":"10.1016\/j.bbadis.2023.166724","volume":"1869","author":"P Umbarkar","year":"2023","unstructured":"Umbarkar P, Ruiz Ramirez SY, Toro Cora A, et al. GSK-3 at the heart of cardiometabolic diseases: Isoform-specific targeting is critical to therapeutic benefit[J]. Biochim Biophys Acta Mol Basis Dis. 2023;1869(6):166724.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"6","key":"10827_CR23","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.2337\/db08-1697","volume":"58","author":"Y Wang","year":"2009","unstructured":"Wang Y, Feng W, Xue W, et al. Inactivation of GSK-3beta by metallothionein prevents diabetes-related changes in cardiac energy metabolism, inflammation, nitrosative damage, and remodeling[J]. Diabetes. 2009;58(6):1391\u2013402.","journal-title":"Diabetes"},{"issue":"13","key":"10827_CR24","doi-asserted-by":"publisher","first-page":"e2307850","DOI":"10.1002\/advs.202307850","volume":"11","author":"X Hu","year":"2024","unstructured":"Hu X, Gan L, Tang Z, et al. A Natural Small Molecule Mitigates Kidney Fibrosis by Targeting Cdc42-mediated GSK-3\u03b2\/\u03b2-catenin Signaling[J]. Adv Sci (Weinh). 2024;11(13):e2307850.","journal-title":"Adv Sci (Weinh)"},{"key":"10827_CR25","doi-asserted-by":"publisher","first-page":"152949","DOI":"10.1016\/j.phymed.2019.152949","volume":"62","author":"Z Zeng","year":"2019","unstructured":"Zeng Z, Wang Q, Yang X, et al. Qishen granule attenuates cardiac fibrosis by regulating TGF-\u03b2 \/Smad3 and GSK-3\u03b2 pathway[J]. Phytomedicine. 2019;62:152949.","journal-title":"Phytomedicine"},{"issue":"5","key":"10827_CR26","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1093\/cvr\/cvad009","volume":"119","author":"R Madonna","year":"2023","unstructured":"Madonna R, Moscato S, Cufaro MC, et al. Empagliflozin inhibits excessive autophagy through the AMPK\/GSK3\u03b2 signalling pathway in diabetic cardiomyopathy[J]. Cardiovasc Res. 2023;119(5):1175\u201389.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10827_CR27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00395-023-01005-1","volume":"118","author":"P Umbarkar","year":"2023","unstructured":"Umbarkar P, Ejantkar S, Ruiz Ramirez SY, et al. Cardiac fibroblast GSK-3\u03b1 aggravates ischemic cardiac injury by promoting fibrosis, inflammation, and impairing angiogenesis[J]. Basic Res Cardiol. 2023;118(1):35.","journal-title":"Basic Res Cardiol"},{"issue":"3","key":"10827_CR28","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.cmet.2017.11.002","volume":"27","author":"J Yoshino","year":"2018","unstructured":"Yoshino J, Baur JA, Imai SI. NAD(+) Intermediates: The Biology and Therapeutic Potential of NMN and NR[J]. Cell Metab. 2018;27(3):513\u201328.","journal-title":"Cell Metab"},{"key":"10827_CR29","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jare.2021.08.003","volume":"37","author":"H Nadeeshani","year":"2022","unstructured":"Nadeeshani H, Li J, Ying T, et al. Nicotinamide mononucleotide (NMN) as an anti-aging health product - Promises and safety concerns[J]. J Adv Res. 2022;37:267\u201378.","journal-title":"J Adv Res"},{"issue":"3","key":"10827_CR30","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s13668-023-00475-y","volume":"12","author":"GFS Alegre","year":"2023","unstructured":"Alegre GFS, Pastore GM. NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health[J]. Curr Nutr Rep. 2023;12(3):445\u201364.","journal-title":"Curr Nutr Rep"},{"key":"10827_CR31","doi-asserted-by":"publisher","first-page":"117524","DOI":"10.1016\/j.taap.2025.117524","volume":"504","author":"YX Yao","year":"2025","unstructured":"Yao YX, Lu X, Li Z, et al. Mitochondrial dysfunction-associated cellular senescence is partially involved in bleomycin-induced pulmonary fibrosis in mice[J]. Toxicol Appl Pharmacol. 2025;504:117524.","journal-title":"Toxicol Appl Pharmacol"},{"key":"10827_CR32","doi-asserted-by":"crossref","unstructured":"Deng H, Ding D, Ma Y et al. Nicotinamide mononucleotide: research process in cardiovascular diseases[J]. Int J Mol Sci. 2024;25(17).","DOI":"10.3390\/ijms25179526"},{"key":"10827_CR33","doi-asserted-by":"crossref","unstructured":"Wang H, Sun Y, Pi C et al. Nicotinamide mononucleotide supplementation improves mitochondrial dysfunction and rescues cellular senescence by nad(+)\/sirt3 pathway in mesenchymal stem cells[J]. Int J Mol Sci. 2022;23(23).","DOI":"10.3390\/ijms232314739"},{"issue":"1","key":"10827_CR34","doi-asserted-by":"publisher","first-page":"28975","DOI":"10.1038\/s41598-025-14349-6","volume":"15","author":"X Zhao","year":"2025","unstructured":"Zhao X, He M, He L, et al. NMN improves cardiac function in SIRT3 knockout mice via the SIRT1\/PGC-1\u03b1 pathway[J]. Sci Rep. 2025;15(1):28975.","journal-title":"Sci Rep"},{"key":"10827_CR35","doi-asserted-by":"crossref","unstructured":"Yu F, Zhao H, Luo L et al. Nicotinamide adenine dinucleotide supplementation to alleviate heart failure: a mitochondrial dysfunction perspective[J]. Nutrients. 2025;17(11).","DOI":"10.3390\/nu17111855"},{"issue":"4","key":"10827_CR36","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00018-013-1349-6","volume":"71","author":"P Kong","year":"2014","unstructured":"Kong P, Christia P, Frangogiannis NG. The pathogenesis of cardiac fibrosis[J]. Cell Mol Life Sci. 2014;71(4):549\u201374.","journal-title":"Cell Mol Life Sci"},{"key":"10827_CR37","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.addr.2021.03.021","volume":"173","author":"M Liu","year":"2021","unstructured":"Liu M, De L\u00f3pez B, Cheng K. Cardiac fibrosis: Myofibroblast-mediated pathological regulation and drug delivery strategies[J]. Adv Drug Deliv Rev. 2021;173:504\u201319.","journal-title":"Adv Drug Deliv Rev"},{"key":"10827_CR38","doi-asserted-by":"publisher","first-page":"101194","DOI":"10.1016\/j.mam.2023.101194","volume":"93","author":"S Ravassa","year":"2023","unstructured":"Ravassa S, L\u00f3pez B, Treibel TA, et al. Cardiac Fibrosis in heart failure: Focus on non-invasive diagnosis and emerging therapeutic strategies[J]. Mol Aspects Med. 2023;93:101194.","journal-title":"Mol Aspects Med"},{"issue":"1","key":"10827_CR39","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12929-017-0379-z","volume":"24","author":"W Ahmad","year":"2017","unstructured":"Ahmad W, Ijaz B, Shabbiri K, et al. Oxidative toxicity in diabetes and Alzheimer\u2019s disease: mechanisms behind ROS\/ RNS generation[J]. J Biomed Sci. 2017;24(1):76.","journal-title":"J Biomed Sci"},{"issue":"21","key":"10827_CR40","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1080\/15384101.2022.2093598","volume":"21","author":"X Zhang","year":"2022","unstructured":"Zhang X, Qu H, Yang T, et al. Astragaloside IV attenuate MI-induced myocardial fibrosis and cardiac remodeling by inhibiting ROS\/caspase-1\/GSDMD signaling pathway[J]. Cell Cycle. 2022;21(21):2309\u201322.","journal-title":"Cell Cycle"},{"issue":"1","key":"10827_CR41","first-page":"26","volume":"12","author":"KJ Chen","year":"2025","unstructured":"Chen KJ, Zhang Y, Zhu XY, et al. GSTM1 suppresses cardiac fibrosis post-myocardial infarction through inhibiting lipid peroxidation and ferroptosis[J]. Mil Med Res. 2025;12(1):26.","journal-title":"Mil Med Res"},{"key":"10827_CR42","doi-asserted-by":"publisher","first-page":"102120","DOI":"10.1016\/j.redox.2021.102120","volume":"46","author":"JA Pan","year":"2021","unstructured":"Pan JA, Zhang H, Lin H, et al. Irisin ameliorates doxorubicin-induced cardiac perivascular fibrosis through inhibiting endothelial-to-mesenchymal transition by regulating ROS accumulation and autophagy disorder in endothelial cells[J]. Redox Biol. 2021;46:102120.","journal-title":"Redox Biol"},{"issue":"2","key":"10827_CR43","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.stem.2021.10.009","volume":"29","author":"V Janbandhu","year":"2022","unstructured":"Janbandhu V, Tallapragada V, Patrick R, et al. Hif-1a suppresses ROS-induced proliferation of cardiac fibroblasts following myocardial infarction[J]. Cell Stem Cell. 2022;29(2):281\u2013e29712.","journal-title":"Cell Stem Cell"},{"issue":"31","key":"10827_CR44","doi-asserted-by":"publisher","first-page":"eadd4222","DOI":"10.1126\/sciadv.add4222","volume":"9","author":"L Meng","year":"2023","unstructured":"Meng L, Lu Y, Wang X, et al. NPRC deletion attenuates cardiac fibrosis in diabetic mice by activating PKA\/PKG and inhibiting TGF-\u03b21\/Smad pathways[J]. Sci Adv. 2023;9(31):eadd4222.","journal-title":"Sci Adv"},{"key":"10827_CR45","doi-asserted-by":"crossref","unstructured":"Nakamura K, Miyoshi T, Yoshida M et al. Pathophysiology and treatment of diabetic cardiomyopathy and heart failure in patients with diabetes mellitus[J]. Int J Mol Sci. 2022;23(7).","DOI":"10.3390\/ijms23073587"},{"key":"10827_CR46","doi-asserted-by":"publisher","first-page":"107515","DOI":"10.1016\/j.phrs.2024.107515","volume":"210","author":"A Rostami","year":"2024","unstructured":"Rostami A, Palomer X, Pizarro-Delgado J, et al. PPAR\u03b2\/\u03b4 prevents inflammation and fibrosis during diabetic cardiomyopathy[J]. Pharmacol Res. 2024;210:107515.","journal-title":"Pharmacol Res"},{"issue":"9","key":"10827_CR47","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1111\/febs.14780","volume":"286","author":"D Zheng","year":"2019","unstructured":"Zheng D, Zhang Y, Hu Y, et al. Long noncoding RNA Crnde attenuates cardiac fibrosis via Smad3-Crnde negative feedback in diabetic cardiomyopathy[J]. Febs j. 2019;286(9):1645\u201355.","journal-title":"Febs j"},{"key":"10827_CR48","doi-asserted-by":"publisher","first-page":"683335","DOI":"10.3389\/fphar.2021.683335","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang Y, Yu K, Zhao C, et al. Follistatin Attenuates Myocardial Fibrosis in Diabetic Cardiomyopathy via the TGF-\u03b2-Smad3 Pathway[J]. Front Pharmacol. 2021;12:683335.","journal-title":"Front Pharmacol"},{"key":"10827_CR49","doi-asserted-by":"publisher","first-page":"109050","DOI":"10.1016\/j.abb.2021.109050","volume":"712","author":"Y Wan","year":"2021","unstructured":"Wan Y, He B, Zhu D, et al. Nicotinamide mononucleotide attenuates doxorubicin-induced cardiotoxicity by reducing oxidative stress, inflammation and apoptosis in rats[J]. Arch Biochem Biophys. 2021;712:109050.","journal-title":"Arch Biochem Biophys"},{"key":"10827_CR50","doi-asserted-by":"publisher","first-page":"119299","DOI":"10.1016\/j.lfs.2021.119299","volume":"274","author":"K Wu","year":"2021","unstructured":"Wu K, Li B, Lin Q, et al. Nicotinamide mononucleotide attenuates isoproterenol-induced cardiac fibrosis by regulating oxidative stress and Smad3 acetylation[J]. Life Sci. 2021;274:119299.","journal-title":"Life Sci"},{"key":"10827_CR51","doi-asserted-by":"crossref","unstructured":"Zhou L, Pinho R, Gu Y et al. The role of SIRT3 in exercise and aging[J]. Cells. 2022;11(16).","DOI":"10.3390\/cells11162596"},{"issue":"1","key":"10827_CR52","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41422-023-00864-6","volume":"34","author":"Y Mao","year":"2024","unstructured":"Mao Y, Zhang J, Zhou Q, et al. Hypoxia induces mitochondrial protein lactylation to limit oxidative phosphorylation[J]. Cell Res. 2024;34(1):13\u201330.","journal-title":"Cell Res"},{"issue":"20","key":"10827_CR53","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1161\/CIRCULATIONAHA.122.059631","volume":"146","author":"L Jin","year":"2022","unstructured":"Jin L, Geng L, Ying L, et al. FGF21-Sirtuin 3 Axis Confers the Protective Effects of Exercise Against Diabetic Cardiomyopathy by Governing Mitochondrial Integrity[J]. Circulation. 2022;146(20):1537\u201357.","journal-title":"Circulation"},{"issue":"1","key":"10827_CR54","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12974-022-02474-2","volume":"19","author":"S Dai","year":"2022","unstructured":"Dai S, Wei J, Zhang H, et al. Intermittent fasting reduces neuroinflammation in intracerebral hemorrhage through the Sirt3\/Nrf2\/HO-1 pathway[J]. J Neuroinflammation. 2022;19(1):122.","journal-title":"J Neuroinflammation"},{"issue":"6","key":"10827_CR55","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1159\/000492651","volume":"48","author":"LF Wang","year":"2018","unstructured":"Wang LF, Huang CC, Xiao YF, et al. CD38 Deficiency Protects Heart from High Fat Diet-Induced Oxidative Stress Via Activating Sirt3\/FOXO3 Pathway[J]. Cell Physiol Biochem. 2018;48(6):2350\u201363.","journal-title":"Cell Physiol Biochem"},{"issue":"5","key":"10827_CR56","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/s41401-022-01026-x","volume":"44","author":"DQ Chen","year":"2023","unstructured":"Chen DQ, Chen L, Guo Y, et al. Poricoic acid A suppresses renal fibroblast activation and interstitial fibrosis in UUO rats via upregulating Sirt3 and promoting \u03b2-catenin K49 deacetylation[J]. Acta Pharmacol Sin. 2023;44(5):1038\u201350.","journal-title":"Acta Pharmacol Sin"},{"key":"10827_CR57","doi-asserted-by":"crossref","unstructured":"Li H, Xu Y, Chen Y et al. Low-dose oral nicotinamide mononucleotide for immune thrombocytopenia: a phase 1\/2 trial[J]. Nat Med. 2026.","DOI":"10.1038\/s41591-026-04366-x"},{"issue":"1","key":"10827_CR58","doi-asserted-by":"publisher","first-page":"102535","DOI":"10.1016\/j.xcrm.2025.102535","volume":"7","author":"K Chaubey","year":"2026","unstructured":"Chaubey K, V\u00e1zquez-Rosa E, Tripathi SJ, et al. Pharmacologic reversal of advanced Alzheimer\u2019s disease in mice and identification of potential therapeutic nodes in human brain[J]. Cell Rep Med. 2026;7(1):102535.","journal-title":"Cell Rep Med"},{"issue":"6","key":"10827_CR59","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.advnut.2023.08.008","volume":"14","author":"Q Song","year":"2023","unstructured":"Song Q, Zhou X, Xu K, et al. The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update[J]. Adv Nutr. 2023;14(6):1416\u201335.","journal-title":"Adv Nutr"}],"container-title":["Journal of Cardiovascular Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-026-10827-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12265-026-10827-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-026-10827-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T16:02:13Z","timestamp":1786377733000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12265-026-10827-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["10827"],"URL":"https:\/\/doi.org\/10.1007\/s12265-026-10827-y","relation":{},"ISSN":["1937-5387","1937-5395"],"issn-type":[{"value":"1937-5387","type":"print"},{"value":"1937-5395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"assertion":[{"value":"23 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Patient Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Laboratory Animal Welfare Ethics Committee of Tianjin Chest Hospital (Approval Document No. TJCH-2023-029, approved on September 8, 2023). And the Committee agrees that the study should be published.","order":2,"name":"Ethics","label":"Animal Ethics Declaration","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As a popular raw material for dietary supplements, the biological benefits of NMN have not yet been fully elucidated. This study further demonstrates that SIRT3 represents a potential therapeutic target for diabetic-induced myocardial fibrosis, providing a novel perspective for investigating the ameliorative effects of NMN in fibrotic diseases.","order":3,"name":"Ethics","label":"Statement of Clinical Relavance","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"102"}}